If you have been reading about GHS-R1a and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic pentapeptide | Chain of five amino acid residues |
| Molecular mass | Approximately 712 Da | Consistent with a five-residue chain |
| Receptor target | GHS-R1a | Growth hormone secretagogue receptor |
| Primary action | Growth hormone release | Pituitary somatotroph stimulation |
| Research origin | Developed in the 1990s | Small-peptide secretagogue program |
Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, a structure that differs from natural ghrelin in length and in the presence of non-natural amino acid residues. Early laboratory work described it as a comparatively selective agent that stimulates growth hormone release with limited effect on other pituitary hormones. The compound is supplied as a lyophilized solid for research use and has no identified natural source in the body.
Activity is mediated mainly through the growth hormone secretagogue receptor, now generally called the ghrelin receptor or GHS-R1a. Binding at this G-protein-coupled receptor triggers phospholipase C signaling, calcium mobilization, and release of growth hormone from pituitary somatotrophs. Reports describe less pronounced stimulation of adrenocorticotropic hormone and prolactin compared with earlier secretagogues such as hexarelin or GHRP-6. Selectivity figures vary between assay systems, so the degree of separation from other secretagogues is an area of ongoing comparison rather than a fixed constant.
Generally feared more than any other Australian snake, the coastal taipan is considered the third-most venomous terrestrial snake in the world, behind the inland taipan and eastern brown snake. It is classified as a snake of medical importance by the World Health Organization. In 1935, local health authorities established a register of cases of injury by plants and animals in northern Queensland. By 1940, one survivor (who lost his sense of smell for some months) and two fatalities had been recorded from coastal taipan bites, with another three historical fatalities added in 1944. George Rosendale, a Guugu Yimithirr man, was bitten through his boots and thick socks while stacking wood. He became sick 15–30 minutes later, with ptosis, nausea, and difficulty breathing, and was conveyed to Cooktown Hospital. A doctor visiting the area on holiday treated him with fluids, and tiger snake antivenom flown up from Cairns. He was flown to Cairns Hospital the next day and was discharged after 19 days. He also reported losing his sense of smell. Rosendale became a Lutheran pastor and died at age 89 in 2019. Articles about how dangerous the species was appeared more frequently in newspapers and books from the late 1930s onwards, including wild tales of it hiding in trees and dropping on victims. Australian naturalist and writer Charles Barrett reported that one had pursued a person for two hours before being killed with a brush hook. After a specimen was found in the Northern Territory in 1947, fears were raised it may occur further south in more populated areas of Queensland.
== Early life, education, and career == Wittman was born in Washington, D.C., the son of adoptive parents Regina C. (née Wood) and Frank Joseph Wittman. His father was of German descent and his mother's ancestors included immigrants from Ireland and Canada. He grew up in Henrico County, Virginia. He attended the Virginia Polytechnic Institute and State University (Virginia Tech) as a member of the Corps of Cadets and Army ROTC and studied biology. While at Virginia Tech, he spent the summers working at a tomato cannery and on a fishing vessel. Also while in college, Wittman was a member of the Delta Tau Delta fraternity. He earned a master's degree in public health from the University of North Carolina at Chapel Hill in 1990 and a Ph.D. from Virginia Commonwealth University in 2002. Wittman worked for 20 years with the Virginia Department of Health. He served as an environmental health specialist and was field director for the Division of Shellfish Sanitation. Wittman served on the Montross Town Council from 1986 to 1996 and as mayor of the Town of Montross from 1992 to 1996. Two of his major initiatives in this office were the overhaul of the sewage system and the development of a computerized system for tax billing. From 1996 to 2005, Wittman served on the Westmoreland County Board of Supervisors, the last two years as chair. He helped create new libraries and pushed for raises in teacher salaries.
The superoxide can then spontaneously or enzymatically react with other molecules to give rise to other ROS. The phagocytic membrane reseals to limit exposure of the extracellular environment to the generated reactive free radicals.
==== Sex-dependent differences ==== Clinical research indicates that the pharmacological effects of amphetamine may vary depending on sex and menstrual cycle phase, possibly due to fluctuations in estrogen and progesterone. In menstruating individuals, subjective and behavioral responses to amphetamine are heightened during the follicular phase (i.e., when estrogen levels are higher), and reduced during the luteal phase (i.e., when progesterone is elevated). Reviews of human studies have also noted that men typically report stronger positive subjective responses to amphetamine compared to women tested during the luteal phase, whereas these sex differences are absent when women are tested during the follicular phase; subjective responses to amphetamine appear to correlate positively with plasma or salivary estrogen concentrations. Moreover, neuroimaging studies have reported significant sex differences in the neural response to amphetamine in humans, including differences in dopamine release within the striatum and other brain regions. Preclinical studies have also produced findings of sex-dependent differences in drug response to amphetamine. In contrast to human studies, adult female rats exhibit markedly greater dopamine release in the nucleus accumbens and more pronounced behavioral effects from amphetamine administration relative to males, effects that may be modulated by fluctuating estradiol levels across the estrous cycle or more broadly by adult gonadal hormones.
=== Small proteins === Small proteins typically have a tertiary structure that is maintained by disulphide bridges (cysteine-rich proteins), metal ligands (metal-binding proteins), and or cofactors such as heme.
Sources: en.wikipedia.org
Elastic fibers are found in the skin, lungs, arteries, veins, connective tissue proper, elastic cartilage, periodontal ligament, fetal tissue and other tissues which must undergo mechanical stretching. In the lung there are thick and thin elastic fibers. Elastic fibers are absent from scarring, keloids and dermatofibromas and they are decreased greatly, or are absent in anetodermas.
Escitalopram, sold under the brand names Lexapro and Cipralex, among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class. It is mainly used to treat major depressive disorder, generalized anxiety disorder, panic disorder, obsessive–compulsive disorder (OCD), and social anxiety disorder. Escitalopram is taken by mouth. For commercial use, it is formulated as an oxalate salt exclusively. Common side effects include headache, nausea, sexual problems, mild sedation, and trouble sleeping. In some patients, sexual dysfunction may persist even after the drug is discontinued, a condition known as post-SSRI sexual dysfunction; regulatory agencies including the European Medicines Agency and Health Canada have recommended that escitalopram's product labeling warn of this risk. More serious side effects may include suicidal thoughts in people up to the age of 24 years. Escitalopram was approved for medical use in the United States in 2002. Escitalopram is rarely replaced by twice the dose of citalopram; escitalopram is safer and more effective. It is on the World Health Organization's List of Essential Medicines. In 2023, it was the second most prescribed antidepressant after sertraline and fourteenth most commonly prescribed medication in the United States, with more than 37 million prescriptions. In Australia, it was one of the top 10 most prescribed medications between 2017 and 2023.
Rodrigo Roa Duterte (born March 28, 1945) is a Filipino former politician who served as the 16th president of the Philippines from 2016 to 2022. He served as mayor of Davao City for three non-consecutive terms between 1988 and 2016. Duterte is the first Philippine president from Mindanao, and the oldest person to assume office, beginning his term at age 71. Duterte is the chairman of PDP–Laban, the ruling party during his presidency. Born in Maasin, Leyte (now in Southern Leyte), Duterte moved to Davao as a child where his father, Vicente Duterte, served as provincial governor. He studied political science at the Lyceum of the Philippines University, graduating in 1968, before obtaining a law degree from San Beda College of Law in 1972. He then worked as a lawyer and prosecutor for Davao City, before becoming vice mayor and, subsequently, mayor of the city in the wake of the 1986 People Power Revolution. Duterte won seven terms and served as mayor of Davao for over 22 years, during which the once crime-ridden city became peaceful and investor-friendly. Duterte's 2016 presidential campaign led to his election victory. During his presidency, his domestic policy focused on combating the illegal drug trade by initiating the controversial war on drugs, fighting crime and corruption, and intensified efforts against terrorism and communist insurgency. He launched a massive infrastructure plan, initiated liberal economic reforms, streamlined government processes, and proposed a shift to a federal system of government which was ultimately unsuccessful.
Generative AI models are used by chatbots such as ChatGPT, programming tools such as GitHub Copilot, text-to-image programs such as Midjourney, and text-to-video programs such as Runway Gen-2. Generative AI features have been added to existing commercially available services such as Microsoft Office (Microsoft Copilot), Google Photos, and the Adobe Suite (Adobe Firefly). Many generative AI models are also available as open-source software, including Stable Diffusion and the LLaMA language model. Smaller generative AI models with up to a few billion parameters can run on smartphones, embedded devices, and personal computers. For example, LLaMA-7B (a version with 7 billion parameters) can run on a Raspberry Pi 4 and one version of Stable Diffusion can run on an iPhone 11. Larger models with tens of billions of parameters can run on laptop or desktop computers. To achieve an acceptable speed, models of this size may require accelerators such as the GPU chips produced by NVIDIA and AMD or the Neural Engine included in Apple silicon products. For example, the 65 billion parameter version of LLaMA can be configured to run on a desktop PC. The advantages of running generative AI locally include protection of privacy and intellectual property, and avoidance of rate limiting and censorship. The subreddit r/LocalLLaMA in particular focuses on using consumer-grade gaming graphics cards through such techniques as compression.
Sources: en.wikipedia.org
== Further reading == De Los Angeles Beytía, Maria; Vry, Julia; Kirschner, Janbernd (2012). "Drug treatment of Duchenne musculardystrophy: available evidence and perspectives". Acta Myologica. 31 (1): 4–8. PMC 3440798. PMID 22655510. Bertini, Enrico; D'Amico, Adele; Gualandi, Francesca; Petrini, Stefania (December 2011). "Congenital Muscular Dystrophies: A Brief Review". Seminars in Pediatric Neurology. 18 (4): 277–288. doi:10.1016/j.spen.2011.10.010. PMC 3332154. PMID 22172424.
== Family == Pedersen was the son of the village schoolteacher Niels Christian Pedersen and Karen Marie (Ane) Pedersen and one of ten children; he was the elder brother of Thorvald Andreas Pedersen (1887–1961), with whom he co-founded Novo Terapeutisk Laboratorium. He married twice: he was widowed in 1916 when his first wife died in childbirth with their fifth child; a few years later he married Ane Thomine Thomsen, and they had a daughter, Gudrun. Gudrun married Knud Hallas-Møller, who later succeeded Harald in leading Novo; their daughter Lise married Mads Øvlisen, who later served as CEO of Novo Nordisk and helped bring about the 1989 merger of Novo and Nordisk.
== Habitat and distribution == Xanthoria parietina is a cosmopolitan species reported from Australia, Africa, Asia, North America, and throughout much of Europe. In eastern North America and Europe, it is more frequently encountered near coastal locations, and in Southern Ontario, Canada, its reappearance has been attributed to increased nitrate deposition associated with industrial and agricultural developments. The species shows a strong preference for coastal habitats, where it benefits from marine aerosol deposition. In Maine, USA, X. parietina is abundant on gravestones near the ocean but declines sharply further inland. It becomes rare beyond 40 km (25 mi) from the coast in southwestern Maine and 130 km (81 mi) inland in eastern Maine. This inland distribution pattern is largely influenced by the deposition of marine-derived nutrients, particularly chloride and sodium, which are transported inland by wind and precipitation. In North America, the species was historically limited primarily to coastal regions—along the Atlantic coast from Newfoundland to Pennsylvania, along the Pacific coast from California to the Pacific Northwest, and in a small part of the Gulf coast in Texas. Within the Pacific Northwest, its traditional range was described as west of the Cascades, from the Willamette Valley to the Puget Sound region. Since the early 2000s, however, the species has been documented in several inland cities in Idaho, Washington, and parts of western Montana.
Sources: en.wikipedia.org
It acts on the growth hormone secretagogue receptor, GHS-R1a, which is also the receptor for ghrelin. Binding triggers intracellular signaling that promotes growth hormone release from the pituitary. The interaction is the basis for its classification as a secretagogue.
In animal studies it showed greater selectivity for growth hormone release, with less effect on cortisol and adrenocorticotropic hormone than compounds such as GHRP-6. This selectivity is one of the most frequently cited features in preclinical literature. Whether the same profile applies in other contexts is not fully established.
The receptor-level events are reasonably well described, but the full range of downstream effects is not. Studies have reported activity in tissues beyond the pituitary, including the gut. How these observations translate across species and conditions remains an open question.
Ipamorelin is a synthetic pentapeptide that stimulates growth hormone release by activating the ghrelin receptor. It is handled as a research tool rather than as a licensed therapeutic product. Its short chain length makes it comparatively simple to synthesize and analyze.